The prognostic significance of troponin elevation in patients with sepsis: A meta-analysis

Heart and Lung: Journal of Acute and Critical Care

Volumn 44, Issue 1, 2015, Pages 75-81

  Sheyin, Olusegun ^a   Davies, Oluwaseun ^a   Duan, Wenlan ^a   Perez, Xavier ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Meta analysis; Mortality; Prognosis; Sepsis; Shock; Troponin

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ARTICLE; HUMAN; MEDICAL SUBJECT HEADINGS; MEDLINE; META ANALYSIS; QUALITY CONTROL; SAMPLE SIZE; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; METABOLISM; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; RISK;

BIOLOGICAL MARKERS; HUMANS; PROGNOSIS; RISK; SEPSIS; SHOCK, SEPTIC; TROPONIN;

EID: 84920618992     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2014.10.002     Document Type: Article

References (38)

1. O'Brien J.M., Ali N.A., Aberegg S.K., Abraham E. Sepsis. Am J Med 2007, 120:1012-1022.
2. Levy M.M., Artigas A., Phillips G.S., et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis Dec 2012, 12(12):919-924.
3. Kumar G., Kumar N., Taneja A., et al. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011, 140:1223-1231.
4. Hall M.J., Williams S.N., DeFrances C.J., Golosinskiy A. Inpatient care for septicemia and sepsis: a challenge for many patients and hospitals. NCHS Data Brief 2011, 62.
5. Wu A.H. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on standardization of cardiac markers (S-SCM). Scand J Clin Lab Invest Suppl 1999, 230:74-82.
6. Mehta N.J., Khan I.A., Gupta V., Jani K., Gowda R.M., Smith P.R. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004, 95:13-17.
7. Ammann P., Maggiorini M., Bertel O., et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003, 41(11):2004-2009.
8. Turner A., Tsamitros M., Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999, 27(9):1775-1780.
9. Spies C., Haude V., Fitzner R., et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998, 113(4):1055-1063.
10. Amman P., Fehr T., Minder E., Gunter C., Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001, 27:965-969.
11. Ver Elst K., Spapen H., Nguyen D., Garber C., Huyghens L., Gorus F. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2001, 46(5):650-657.
12. Innocenti F., Bianchi S., Guerrini E., et al. Prognostic scores for early stratification of septic patients admitted to an emergency department-high dependency unit. Eur J Emerg Med 2014, 21(4):254-259.
13. Tiruvoipati R., Sultana N., Lewis D. Cardiac troponin I does not independently predict mortality in critically ill patients with severe sepsis. Emerg Med Australas 2012, 24(2):151-158.
14. Brivet F., Jacobs F., Colin P., Prat D., Grigoriu B. Cardiac troponin level is not an independent predictor of mortality in septic patients requiring medical intensive care unit admission. Crit Care 2006, 10(1):404.
15. Bessière F., Khenifer S., Dubourg J., Durieu I., Lega J. Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med 2013, 9(7):1181-1189.
16. Rosjo H., Varpula M., Karlsson S., Ruokonen E., Pettila V., Omland T. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011, 37:77-85.
17. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAm Med Assoc 2000, 283:2008-2012.
18. Higgins JPT, Green S. (Eds.), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011], 2011, The Cochrane Collaboration.
19. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20(6):864-874.
20. Levy M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference,. Intensive Care Med 2003, 29(4):530-538.
21. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
22. Quenot J., Teuf G., Quantin C., et al. Myocardial Injury in critically ill patients, relation to increased cardiac troponin I and hospital mortality. Chest 2005, 128(4):2758-2764.
23. Sturgess D., Marwick T., Joyce C., et al. Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care 2010, 14(12):R44.
24. Yucel T., Memis D., Karamanlioglu B., Necdet S., Yuksel M. The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis. Exp Clin Cardiol 2008, 13(4):183-188.
25. King D., Codish S., Novack V., Barski L., Almog Y. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care 2005, 9:R390-R395.
26. Wright R., Williams B., Crammer H., et al. Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am J Cardiol 2002, 90:634-636.
27. Kang E.W., Na H.J., Hong S.M., et al. Prognostic value of elevated troponin I in ESRD patients with sepsis. Nephrol Dial Transplant 2009, 24:1568-1573.
28. John J., Woodward D.B., Wang Y., et al. Troponin-I as a prognosticator of mortality in severe sepsis patients. JCrit Care 2010, 25:270-275.
29. Fernandes C.J., Akamine N., Knobel E. Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 1999, 25:1165-1168.
30. Scott E.C., Ho H.C., Yu M., Chapital A.D., Koss W., Takanishi D.M. Pre-existing cardiac disease, troponin I elevation and mortality in patients with severe sepsis and septic shock. Anaesth Intensive Care 2008, 36:51-59.
31. John J., Awab D., Norman T., Dernaika T., Kinasewitz G.T., et al. Activated protein C improves survival in severe sepsis patients with elevated troponin. Intensive Care Med 2007, 33:2122-2128.
32. Bouhemad B., Nicolas-Robin A., Arbelot C., Arthaud M., Feger F., Rouby J., et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 2008, 36(3):767-774.
33. Choon-ngarm, Partpisanu P. Serum cardiac troponin-T as a prognostic marker in septic shock. J Med Assoc Thai 2008, 91:1818-1821.
34. Issa L., Taniguchi M., Park M., et al. Positive end-expiratory pressure and renal function influence B-type natriuretic peptide in patients with severe sepsis and septic shock. Arq Bras Cardiol 2008, 91(2):1-11.
35. Landesberg G., Jaffe A., Gilon D., et al. Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation. Crit Care Med 2014, 42(4):1-11.
36. Guest T.M., Ramanathan A.V., Tuteur P.G., Schechtman K.B., Ladenson J.H., Jaffe A.S., et al. Myocardial injury in critically ill patients. A frequently unrecognized complication. J Am Med Assoc 1995, 273:1945-1949.
37. Zhang X., Qin Y., Bian X., Dong S. Effects of fluid resuscitation on myocardial injury in patients with severe sepsis and septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012, 24(4):212-224.
38. Patel J.M., Thickett D.R., Linhartova L., et al. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS trial). Crit Care 2012, 16:R231.